| 74.79 Data as of May 24 | +0.96 / +1.30%Today’s Change | 56.21 Today|||52-Week Range 79.75 | +16.04% Year-to-Date |
| Previous close | 73.83 |
| Today’s open | 74.25 |
| Day’s range | 74.25 - 74.80 |
| Volume | 300 |
| Average volume (3 months) | 849 |
| Market cap | $46.6M |
| Dividend yield | 0.96% |
| Earnings growth (last year) | -13.29% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +12.72% |
| P/E ratio | 8.1 |
| Price/Sales | 0.03 |
| Price/Book | 0.92 |
| Today’s change | Today’s % change | |
|---|---|---|
| PHRXPharmagen Inc | +0.00 | +0.32% |
| SCRCScripsAmerica Inc | +0.01 | +8.97% |
| AGXArgan Inc | -0.07 | -0.44% |
| ACETAceto Corp | -0.08 | -0.67% |
| Last reporting date | -- |
| EPS forecast (this quarter) | -- |
| Annual revenue (last year) | $1.2B |
| Annual profit (last year) | $7.4M |
| Net profit margin | 0.63% |
Sector Distribution Services |
Industry Wholesale Distributors |
Chairman, CEO & Head-Investor Relations Christopher H. Atayan |
President & Director Kathleen M. Evans |
Corporate headquarters Omaha, Nebraska |
